Company founded in 2019 by neuroscientist Mendel Kaelen providing adaptive, person-centered music software designed for psychedelic and ketamine-assisted therapy, generated in real time to support sessions. It collaborates with musicians and raised roughly $4.5M from investors including Bridge Builders Collaborative and Palo Santo.